Latest News
Skychain Closes Private Placement
Vancouver, British Columbia–(Newsfile Corp. – January 14, 2022) – Skychain Technologies Inc. (TSXV: SCT) (OTCQB: SKTCF) (“Skychain” or the “Company”) is pleased to announce that the Company has successfully completed its non-brokered private placement (the “Private Placement”) described in its news release on December 31, 2021.
Under the Private Placement the Company issued 2,757,475 common shares of the Company (the “Shares”) at a price of $0.42 per Share for gross proceeds of $1,158,140. The proceeds from the Private Placement will be used for general and administrative expenses and for current and new project evaluation and development. All securities issued pursuant to the Private Placement will be subject to a hold period of four months and one day.
Two directors and the spouse of a director of the Company (the “Insiders”) participated in the Private Placement and purchased a total of 210,595 Shares. As such, the Private Placement is a related party transaction as such term is defined in TSX Venture Exchange Policy 5.9 and Ontario Securities Commission Multilateral Instrument 61-101 (“MI61-101”).
The Private Placement is exempt from the requirements for a formal valuation set out in Section 5.4 of MI61-101 since the transaction is a distribution of securities for cash and neither the Company nor, to the knowledge of the Company after reasonable inquiry, any of the Insiders has knowledge of any material information concerning the Company or its securities that has not been generally publicly disclosed. The Private Placement has been approved by the Company’s disinterested directors. The Private Placement is exempt from the requirements in Section 5.7 of MI61- 101 for approval by its minority shareholders since the fair market value of the transaction is less than $2,500,000.
About Skychain Technologies Inc.
Skychain Technologies Inc. is a Vancouver based company providing Blockchain Infrastructure and valued added services. To learn more, visit skychaintechnologiesinc.com
ON BEHALF OF THE BOARD OF DIRECTORS
Dr. Richard Du
Chairman and Chief Executive Officer
______________________________________________________________________
Contact: 604-688-5464
[email protected]
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of TSX Venture Exchange) accepts responsibility for the adequacy of accuracy of this release.
Statements in this news release may be viewed as forward-looking statements. Such statements involve risks and uncertainties that could cause actual results to differ materially from those projected. There are no assurances the company can fulfill such forward-looking statements and the company undertakes no obligation to update such statements. Such forward-looking statements are only predictions; actual events or results may differ materially as a result of risks facing the company, some of which are beyond the company’s control.
NOT FOR DISTRIBUTION TO US NEWS WIRE SERVICES OR FOR DISSEMINATON INTO THE USA
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/110130
Powered by WPeMatico
Latest News
Morgan Stanley B.V. – annual report and financial statements for the financial year ended 31 December 2023
AMSTERDAM, April 26, 2024 /PRNewswire/ — Morgan Stanley B.V. hereby announces that the annual report and financial statements for the financial year ended 31 December 2023 as expressed in article 5.25c of the Act on Financial Supervision (“Wet op het financieel toezicht”) has been made public and is available on the Morgan Stanley website:
View original content:https://www.prnewswire.co.uk/news-releases/morgan-stanley-bv–annual-report-and-financial-statements-for-the-financial-year-ended-31-december-2023-302128836.html
The content and accuracy of news releases published on this site and/or distributed by PR Newswire or its partners are the sole responsibility of the originating company or organisation. Whilst every effort is made to ensure the accuracy of our services, such releases are not actively monitored or reviewed by PR Newswire or its partners and under no circumstances shall PR Newswire or its partners be liable for any loss or damage resulting from the use of such information. All information should be checked prior to publication.
Latest News
United Imaging Healthcare releases 2023 annual report, with revenue growth of 23.52%
Along with the publication of its 2023 annual report and the Q1 2024 report, United Imaging Healthcare released its ESG report.
SHANGHAI, April 26, 2024 /PRNewswire/ — United Imaging Healthcare (SSE:688271), a global leader in manufacturing advanced medical imaging and radiotherapy equipment, has released their 2023 annual report. The report reveals that the company achieved 11.41 billion CNY in revenue in 2023, marking a stable increase of 23.52%. Net income attributable to the shareholders of the parent company was 1.97 billion CNY, reflecting a YoY increase of 19.21 %.
The company also released its first quarter report for 2024. The report shows that in Q1 2024, United Imaging Healthcare recorded revenue of 2.35 billion CNY and net income attributable to the shareholders of 0.36 billion CNY, an increase of 6.22% and 10.20% respectively.
In the past year, United Imaging Healthcare has adhered to their globalization strategy, expanding the sales network to cover major developed and emerging markets around the world. By the end of 2023, the company’s global customer base had covered over 65 countries and regions. The company has obtained more than 700 product registration certificates or quality management system certifications, with 45 products receiving CE certification and 44 products passing FDA 510(k) registrations, allowing them to be commercially available in the US. In 2023, the company’s overseas main business achieved YoY growth of over 54.72 %, reaching 1.68 billion CNY. Notably, sales of the company’s high-end equipment experienced rapid growth.
The expanding market share is bolstered by the company’s steadfast commitment to research and development (R&D) innovation. The report illustrates that United Imaging Healthcare has made substantial investments in enhancing its technology and solutions in 2023, totaling 1.92 billion CNY.
In the past few years, United Imaging Healthcare has made new breakthroughs in collaborating with world-renowned universities and clinical and scientific research institutions such as Yale University and UC Davis, resulting in pioneering advancements like the advanced molecular imaging device for the brain. Complementing these collaborations, the company’s commitment to healthcare accessibility is demonstrated by initiatives like partnering with GIC Prime in India and deploying a mobile PET/CT unit in Piacenza, Italy. These efforts underscore United Imaging Healthcare’s dedication to “Equal Healthcare for All.”
To embrace sustainability, United Imaging Healthcare always adheres to the core values of “DEI,” which is diversity, equity, and inclusivity,” regards employees as the core driving force to promote sustainable development of the enterprise, and firmly protects the basic rights of employees.
United Imaging Healthcare is committed to promoting a green enterprise and bolstering climate-related initiatives as a foundation for sustainable growth. The company’s dedication is evident through continual enhancements to its environmental management system, adoption of eco-friendly and energy-efficient production methods, and vigilant monitoring of global climate shifts. As they pursue their own journey towards sustainability and strive for high-quality development, United Imaging Healthcare actively contributes to advancing ecological progress on a global scale.
About United Imaging Healthcare
At United Imaging Healthcare, we develop and produce advanced medical products, digital healthcare solutions, and intelligent solutions that cover the entire process of imaging diagnosis and treatment.
Founded in 2011, our company has subsidiaries and R&D centers across China, the United States, Poland, Dubai, and other parts of the world. With a cutting-edge digital portfolio and a mission of Equal Healthcare for All™, we help drive industry progress and bold change.
To learn more, visit https://www.united-imaging.com
View original content:https://www.prnewswire.co.uk/news-releases/united-imaging-healthcare-releases-2023-annual-report-with-revenue-growth-of-23-52-302128731.html
Latest News
Former Tesla executive Tim Newell is set to spin off Aspiration’s consumer financial services division.
-
Latest News7 days ago
HSBC-backed fintech Monese is considering splitting its operations as it grapples with increasing losses.
-
Latest News7 days ago
EverBank has announced a groundbreaking partnership with Finzly, poised to revolutionize payment processing.
-
Latest News7 days ago
FinTech leaders express caution regarding the promises made in #Budget2024 concerning open banking, stating that the “devil is in the details.”
-
Latest News6 days ago
Aurionpro Solutions acquires Arya.ai, to power next generation Enterprise AI platforms for Financial Institutions
-
Latest News6 days ago
Gotion High-tech’s operating profit up 391% in 2023, nearly RMB 2.8 billion invested in R&D for the year
-
Latest News7 days ago
Wells Fargo, a leading financial institution, is set to revolutionize its trade finance operations by incorporating artificial intelligence (AI) technology through its collaboration with TradeSun.
-
Latest News6 days ago
Latvian Fintech inGain Raises €650,000 for No-Code SaaS Loan Management System
-
Latest News6 days ago
Credit card fintech Pliant lands €18m Series A extension led by PayPal Ventures